<?xml version="1.0" encoding="UTF-8"?><rss xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:atom="http://www.w3.org/2005/Atom" version="2.0"><channel><title><![CDATA[Fra blogbuster: The CHMP met today and has given Darzalex the green light: Dara wins EMA backing for approval. It shouldn’t be long now before official EMA registration. A great way to close an awesom]]></title><description><![CDATA[<p dir="auto">Fra blogbuster: The CHMP met today and has given Darzalex the green light: Dara wins EMA backing for approval. It shouldn’t be long now before official EMA registration. A great way to close an awesome week… Today, the Committee has issued a positive opinion recommending the grant of a conditional marketing authorisation for Darzalex in the EU for treatment of relapsed and refractory multiple myeloma. Darzalex has an orphan designation and was reviewed under EMA’s accelerated assessment scheme.</p>
]]></description><link>https://dev.proinvestor.com/forum/topic/398391/fra-blogbuster-the-chmp-met-today-and-has-given-darzalex-the-green-light-dara-wins-ema-backing-for-approval-it-shouldnt-be-long-now-before-official-ema-registration-a-great-way-to-close-an-awesom</link><generator>RSS for Node</generator><lastBuildDate>Sun, 07 Jun 2026 07:39:42 GMT</lastBuildDate><atom:link href="https://dev.proinvestor.com/forum/topic/398391.rss" rel="self" type="application/rss+xml"/><pubDate>Thu, 16 Feb 2023 10:10:39 GMT</pubDate><ttl>60</ttl></channel></rss>